Who we are
The mission of TGN is to advance transactions in the life sciences space in every aspect, as well as securing life sciences regulatory law as a building block in these transactions.
The Genotype Network (TGN) lawyers do not only understand the essence of a Life Sciences transaction, but due to their long-standing experience, they thoroughly grasp the commercial impact of particular aspects on the purchase price and the transaction as a whole. For this reason, TGN advises to start with a preliminary DD during purchase price negotiations in order to be able to better valuate the target.
TGN aims to build a trust-based community with a view to thoroughly optimize the success of transactions, investments, and IPO’s in the life sciences space.
TGN Members are highly experienced lawyers and partners in these sectors. Corporate transactions in the highly regulated life sciences space are a special breed. Highly experienced regulatory lawyers have the capacity to assess the deal to its core and therewith, its actual value. More and more regulatory issues go to price or valuation.
The stakes are high, and regulatory aspects may make or break the future earnings of the target. In other words, regulatory aspects may affect the entire life-span of the deal.
We are at the verge of harvesting the fruits of the Bio Revolution, with its convergence of science and technology. Therefore, deals in this sector are becoming increasingly complex and therefore need regulatory prowess. TGN provides access to highly specialised and experienced regulatory lawyers to its Members on a global scale.
Which Genotype are you?
Members of The Genotype Network (TGN Members) benefit from the network and advance the transactions they work in.
Which Genotype are you?
Genotype Regs lawyer:
Regulatory lawyers are the thought leaders in the life sciences sector. They form a crucial building block in life sciences transactions within TGN.
Genotype corporate (M&A) lawyer:
As a corporate lawyer, you can rely on the regulatory prowess (expertise) of the Regulatory lawyers, so the deal is better thought-out and less likely to bump into issues at a crucial stage. European corporate lawyers are somewhat less specialized as compared to their US counterparts and that is where TGN comes in.
